T 0858/13 (Antagonistic anti-NGF antibodies for use in bone cancer pain treatment/RINAT NEUROSCIENCE, REGENTS OF THE UNIVERSITY OF MINNESOTA) of 11.04.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T085813.20170411
- Date of decision
- 11 April 2017
- Case number
- T 0858/13
- Petition for review of
- -
- Application number
- 05777592.6
- IPC class
- C07K 16/22
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods for treating bone cancer pain by administering a nerve growth factor antagonist
- Applicant name
- Rinat Neuroscience Corp.
Regents of the University of Minnesota - Opponent name
- Regeneron Pharmaceuticals, Inc.
Adams, Harvey Vaughan John
Sanofi-Aventis U.S. Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Main request: Inventive step (no)
Admission of auxiliary requests filed during oral proceedings (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal of appellants I is dismissed.
2. The decision under appeal is set aside.
3. The patent is revoked.